Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01243983 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis
A Phase 3 study, sponsored by Lux Biosciences.
- Completed
- Registry status
- Phase 3
- Development phase
- 155
- Enrollment target
NCT01243983: Completed Phase 3 study, sponsored by Lux Biosciences.
NCT01243983 is a Phase 3 study that has completed, run by Lux Biosciences. The registered enrollment target is 155 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01243983, a Phase 3 study, has completed, sponsored by Lux Biosciences.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 155 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the safety and efficacy of voclosporin as therapy in subjects with active noninfectious uveitis involving the intermediate and/or posterior segments of the eye (i.e., anterior + intermediate-, intermediate-, posterior- or pan-uveitis).
Interventions
- DRUG LX211
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-12 |
| Phase | Phase 3 |
What the finished NCT01243983 record still lists
NCT01243983 is an interventional study that assigns participants to a tested intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 1 intervention - of which LX211 is the first listed.
NCT01243983 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01243983 about?
NCT01243983 is a clinical study titled "Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis". The primary objective of this study is to assess the safety and efficacy of voclosporin as therapy in subjects with active noninfectious uveitis involving the intermediate and/or posterior segments of the eye (i.e., anterior + intermediate-, intermediate-, posterior- or pan-uveitis).
What is the current status of trial NCT01243983?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 155 participants. The study started on 2011-02. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01243983?
The interventions under investigation include: LX211 (DRUG).
Who is sponsoring clinical trial NCT01243983?
This trial is sponsored by Lux Biosciences, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01243983's enrollment target sits among peer trials
155 1509th of 2000 higher than 492 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223610 · 155 participants · Phase 1
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- NCT05072483 · 155 participants
Natural History Study of CADASIL
- NCT05086497 · 155 participants · NA
WBSI Guided Personalized Delivery of TTFields
- NCT05412069 · 155 participants · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia